Issues in COVID-19 research and statistical analyses (Part XVVXVVV)
December 5, 2022 A recent article that appeared December 1 in JAMA Open Network shows the retrospective analysis of Remdesivir treatment for inpatient mortality among COVID-19 patients using insurance claims data amongst 24,856 adults hospitalized between May 1, 2020...
Issues in COVID-19 research and statistical analyses (Part XVVXVVIV)
Issues in COVID-19 research and statistical analyses (Part XVVXVVIV) November 23, 2022 In an article from November 11, 2022 in Health News from NPR, Rob Stein lays out the likelihood of two new Omicron subvariants, BQ.1 and BQ.11 of SARS-Cov-2 having become dominant...
Issues in COVID-19 research and statistical analyses (Part XVVXVVIII)
November 9, 2022 In a recent article from November 1 in Science Immunology, the authors reported on their analysis of T-cell immunity four weeks and six months after different vaccination regimens and four weeks after an additional booster vaccination. This was a...
Issues in COVID-19 research and statistical analyses (Part XVVXVVII)
October 26, 2022 In a letter to the editor, the authors stated that they previously reported on the incidence of myocarditis in Israel after receipt of the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) against coronavirus disease 2019 (Covid-19) to have been the...
Issues in COVID-19 research and statistical analyses (Part XVVXVVI)
October 13, 2022 A recent article in JAMA, “Association of Primary and Booster Vaccination and Prior Infection With SARS-CoV-2 Infection and Severe COVID-19 Outcomes” focuses on looking at the association of COVID-19 vaccination and boosters or prior infection with...
Issues in COVID-19 research and statistical analyses (Part XVVXVV)
September 26, 2022 A recent article in New Medical Life Sciences, “Researchers explore neurological manifestations among long COVID patients” focuses on an article that appeared in Nature Medicine regarding a published study on assessing long-term neurological...
Issues in COVID-19 research and statistical analyses (Part XVVXVIV)
September 14, 2022 According to a recent article in Nature Communications, regular rapid testing provided two-fold benefits: identifying infectious individuals and providing positive tests sufficiently early during infection that treatment with antivirals can...
Issues in COVID-19 research and statistical analyses (Part XVVXVIII)
August 31, 2022 In a recent article in NEJM that appeared this month, researchers conducted a double-blind randomized placebo-controlled trial of metformin, ivermectin, and fluvoxamine to study their effectiveness against outcomes related to COVID-19. They used a 2x3...
Issues in COVID-19 research and statistical analyses (Part XVVXVII)
August 17, 2022 In a recent article in Asthma and Allergy, Sohn et al discuss what the impacts were for patients with severe asthma who wore masks during the pandemic in South Korea. Patients in the study were recruited from 5 university hospitals in 3 different...
Issues in COVID-19 research and statistical analyses (Part XVVXVI)
August 3, 2022 In a recent article in BMJ Global Health, James et al discuss a statistical analysis they performed on retrospective data on SARS-CoV-2 infections during the first wave of the COVID-19 pandemic in sub-Saharan African countries using World Health...